ATNM

Actinium Pharmaceuticals, Inc. SEC filings

Every EDGAR filing for Actinium Pharmaceuticals, Inc. (ATNM), newest first, with AI summaries and stories.

Ticker
ATNM
CIK
1388320
Sector
Biotech and pharma
Latest filing
2d

Next: 10-Q expected ~Nov 9 (deadline Nov 16)

Watch in the app Get the app

Get an email when Actinium Pharmaceuticals, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Insider activity

No open-market insider buys in the last 30 days.

Also: 1 grant or exercise.

All ATNM insider trades

Filings

  1. 4Actinium Pharmaceuticals, Inc.ATNM

    2 insider filings

    Matthew T David, insider filing for ATNM

    Show all 2
    • 4Insider filing for ATNM
    • 3New insider at ATNM

    Matthew T David, reporting

  2. 3Actinium Pharmaceuticals, Inc.ATNM

    2 insider filings

    Steffen Wilhem Heeger, new insider at ATNM

    Show all 2
    • 3New insider at ATNM
    • 3New insider at ATNM

    Steffen Wilhem Heeger, reporting

  3. 4Actinium Pharmaceuticals, Inc.ATNM

    6 insider filings

    Sandesh Seth, insider filing for ATNM

    Show all 6
    • 4Insider filing for ATNM
    • 4Insider filing for ATNM
    • 4Insider filing for ATNM
    • 4Insider filing for ATNM
    • 4Insider filing for ATNM
    • 4Insider filing for ATNM

    Sandesh Seth, reporting

Older filings on EDGAR